{"disease":{"id":"neoplasms-connective-and-soft-tissue","name":"neoplasms connective and soft tissue"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02677961","title":"An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT07547592","title":"Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":92,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04910126","title":"Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05160168","title":"A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":32,"lead_sponsor_name":"Theseus Pharmaceuticals","has_results":true},{"nct_id":"NCT03495921","title":"A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":32,"lead_sponsor_name":"Gradalis, Inc.","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}